Title: <b>A Synopsis:</b> Neurocardiogenic Syncope, An International Symposium, 1996
Abstract: Pacing and Clinical ElectrophysiologyVolume 20, Issue 3 p. 851-860 A Synopsis: Neurocardiogenic Syncope, An International Symposium, 1996 DAVID G. BENDITT, Corresponding Author DAVID G. BENDITT University of Minnesota Medical School, MinneapolisAddress for reprints: David G. Benditt, M.D., Cardiac Arrhythmia Center, University of Minnesota Medical School, Box 508 UMHC, Minneapolis, MN 55455. Fax: (612) 624-4937.Search for more papers by this authorMARK ERICKSON, MARK ERICKSON Medtronic, Inc., Minneapolis, MinnesotaSearch for more papers by this authorMICHAEL D. GAMMAGE, MICHAEL D. GAMMAGE Department of Cardiology, Queen Elizaheth Hospital, Birmingham, United KingdomSearch for more papers by this authorTOBY MARKOWITZ, TOBY MARKOWITZ Medtronic, Inc., Minneapolis, MinnesotaSearch for more papers by this authorRICHARD SUTTON, RICHARD SUTTON Department of Cardiology, Royal Brompton Hospital, London, United KingdomSearch for more papers by this author DAVID G. BENDITT, Corresponding Author DAVID G. BENDITT University of Minnesota Medical School, MinneapolisAddress for reprints: David G. Benditt, M.D., Cardiac Arrhythmia Center, University of Minnesota Medical School, Box 508 UMHC, Minneapolis, MN 55455. Fax: (612) 624-4937.Search for more papers by this authorMARK ERICKSON, MARK ERICKSON Medtronic, Inc., Minneapolis, MinnesotaSearch for more papers by this authorMICHAEL D. GAMMAGE, MICHAEL D. GAMMAGE Department of Cardiology, Queen Elizaheth Hospital, Birmingham, United KingdomSearch for more papers by this authorTOBY MARKOWITZ, TOBY MARKOWITZ Medtronic, Inc., Minneapolis, MinnesotaSearch for more papers by this authorRICHARD SUTTON, RICHARD SUTTON Department of Cardiology, Royal Brompton Hospital, London, United KingdomSearch for more papers by this author First published: 30 June 2006 https://doi.org/10.1111/j.1540-8159.1997.tb03921.xCitations: 15AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Benditt DG, Ferguson DW, Grubb BP, et al. ACC expert consensus document: Tilt table testing for assessing syncope. J Am Coll Cardiol 1996; 28: 263–275. 2 Van Lieshout JJ, Wieling W, Karemaker JM, et al. The vasovagal response. Clin Sci 1991; 81: 575–586. 3 Kosinski D, Grubb B, Temesy-Armos P. Patho-physiological aspects of neurocardiogenic syncope: Current concepts and new perspectives. PACE 1995; 18: 716–724. 4 Benditt DG, Lurie KG, Adler SW, et al. Rationale and methodology of head-up tilt table testing for evaluation of neurally mediated (cardioneurogenic) syncope. In DP Zipes, J Jalife (eds.): Cardiac Electrophysiology. From Cell to Bedside. 2nd ed. Philadelphia , PA , WB Saunders Co., 1995, pp. 1115–1128. 5 Sutton R, Petersen M, Brignole M, et al: Proposed classification for tilt induced vasovagal syncope. Eur JCPE 1992; 2: 180–183. 6 Njemanze PC. Critical limits of pressure-flow relation in the human brain. Stroke 1992; 23: 1743–1747. 7 Grubb BP, Gerard G, Roush K, et al. Cerehral vasoconstriction during head-upright tilt-induced vasovagal syncope. Circulation 1991; 84: 1157–1164. 8 Diehl RR, Linden D, Chalkiadaki K, et al. Transcranial Doppler during neurocardiogenic syncope. Clin Autonom Res 1996; 6: 71–74. 9 Tea SH, Mansourati J, L'Heveder G, et al. New insights into the pathophysiology of carotid sinus syndrome. Circulation 1996; 93: 1411–1416. 10 Donald DE, Shepherd JT. Reflexes from the heart and lungs: Physiological curiosities or important regulatory mechanisms. CardioVasc Res 1978; 12: 449–469. 11 Abboud FM, Thames MD. Interaction of cardiovascular reflexes in circulatory control. In JT Shepherd, FM Abboud (eds.): Handbook of Physiology. Section 2: The Cardiovascular System. Peripheral Circulation and Organ Blood Flow. American Physiological Society, Bethesda , MD , 1983, pp. 675–753. 12 Pema GP, Ficola U, Salvatori MP, et al. Increase of plasma beta endorphins in vasodepressor syncope. Am J Cardiol 1990; 65: 929–930. 13 Faden AI, Jacobs TP, Holaday JW. Opiate antagonist improves neurologic recovery after spinal injury. Science 1981; 211: 493–494. 14 Rutter PC, Potocnik SJ, Ludbrook J. Sympathoadrenal mechanisms in cardiovascular responses to naloxone after hemorrhage. Am J Physiol 1987; 252: H40–H46. 15 Evans RG, Ludbrook J, Potocnik SJ. Intracisternal naloxone and cardiac nerve blockade prevent vasodilatation during simulated hemorrhage in awake rabbits. J Physiol (Lond) 1989; 409: 1–14. 16 Smith ML, Carlson MD, Thames MC. Naloxone does not prevent vasovagal syncope during simulated orthostasis in humans. J Autonom Nerv Syst 1993; 45: 1–9. 17 Kosinski D, Grubb BP, Temesy-Armos P. The use of serotonin reuptake inhibitors in the treatment of neurally mediated cardiovascular disorders. J Serotonin Res 1994; 1: 85–90. 18 Sakuma I, Togashi H, Yoshioka M, et al. NG-Methyl-L-Arginine, an inhibitor of L-Arginine-de-rived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: A role for nitric oxide in the central regulation of sympathetic tone Circ Res 1992; 70: 607–611. 19 Kaufmann H, Berman J, Oribe E, et al. Possible increases in EDRF/NO in neurally mediated syncope, (abstract) Clin Autonom Res 1993; 3: 69. 20 Dietz NM, Rivera JM, Eggener SE, et al. Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans. J Physiol (Lond) 1994; 480: 361–368. 21 Dietz NM, Joyner MJ, Shepherd JT. Vasovagal syncope and skeletal muscle vasodilatation. The continuing conundrum. PACE 1997; 20(Pt. II): 775–780. 22 Sander-Jensen K, Secher NH, Astrup A, et al. Hypotension induced by passive head-up tilt: Endocrine and circulatory mechanisms. Am J Physiol 1986; 251: R742–R748. 23 Fitzpatrick A, Williams T, Jeffrey C, et al. Pathogenic role for arginine vasopressin (AVP) and catecholamines (EP & NEP) in vasovagal syncope, (abstract) J Am Coll Cardiol 1990; 15: 98. 24 Thames MD, Schmid PG. Interaction between carotid and cardiopulmonary bairoreflexes in control of plasma ADH. Am J Physiol 1981; 241: H431–H441. 25 Beiser GD, Zelis R, Epstein SE, et al. The role of skin and muscle resistance vessels in reflexes mediated by the baroreceptor system. J Clin Invest 1970; 49: 225–231. 26 Wallin BG, Sundlof G. Sympathetic outflow in muscles during vasovagal syncope. J Autonom Nerv Syst 1982; 6: 287–291. 27 Goldstein DS, Spanarkel M, Pitterman A, et al. Circulatory control mechanisms in vasodepressor syncope. Am Heart J 1982; 104: 1071–1075. 28 Ellenhogen KA, Morillo CA, Wood MA, et al. Neural monitoring of vasovagal syncope. PACE 1997; 6(Pt. II): 788–794. 29 Blair DA, Glover WE, Greenfield ADM, et al. Excitation of cholinergic vasodilator nerves to human skeletal muscles during emotional stress. J Physiol (Lond) 1959; 148: 633–647. 30 Brody MJ. Histaminergic and cholinergic vasodilator systems. In PM Vanhoutte, I Leusen (eds.): Mechanisms of Vasodiiatation. Basel S , Karger AG, 1978, pp. 266–277. 31 Bevan JA, Brayden JE. Nonadrenergic neural vasodilator mechanisms. Circ Res 1987; 60: 309–326. 32 Kellogg DL, Johnson JM, Kosiha WA. Baroreflex control of the cutaneous active vasodilator system in humans. Circ Res 1990; 66: 1420–1426. 33 Van Lieshout JJ, Wieling W, Karemaker JM. Neural circulatory control in vasovagal syncope. PACE 1997; 6(Pt. II): 753–763. 34 Burnstock G. Purinergic nerves. Pharmacol Rev 1972; 24: 509–581. 35 Perry JC, Garson A Jr. The child with recurrent syncope: Autonomic function testing and beta-adrenergic hypersensitivity. J Am Coll Cardiol 1991; 17: 1168–1171. 36 Muscholl E. Peripheral muscarinic control of nore-pinephrine release in the cardiovascular system. Am J Physiol 1980; 239: H713–720. 37 Levy MN. Cardiac sympathetic-parasympathetic interactions. Fed Proc 1984; 43: 2598–2602. 38 Potter EK. Prolonged non-adrenergic inhibition of cardiac vagal action by sympathetic stimulation: Neuromodulation by neuropeptide-Y Neurosci Lett 1985; 54: 117–121. 39 Potter EK. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide-Y. Neurosci Lett 1987; 83: 101–106. 40 Warner MR, Levy MN. Inhibition of cardiac vagal effects by neurally released and exogenous neu-ropeptide Y. Circ Res 1989; 65: 1536–1546. 41 Revington ML, McCloskey DI. Sympathetic-parasympathetic interactions at the heart, possibly involving neuropeptide Y, in anaesthetized dogs. J Physiol (Lond) 1990; 428: 359–370. 42 Benditt DG, Chen M-Y, Hansen R, et al. Characterization of subcutaneous microvascular blood flow during tilt-table-induced neurally mediated syncope. J Am Coll Cardiol 1995; 25: 70–75. 43 Adler PSJ, France C, Ditto B. Baroreflex sensitivity at rest and during stress in individuals with a history of vasovagal syncope. J Psychsomat Res 1991; 35: 591–597. 44 Kenny RA, Bayliss J, Ingram A, et al. Head up tilt: a useful test for investigating unexplained syncope. Lancet 1986; 1: 1354. 45 Grubb BP, Kosinski D. Tilt table testing: Concepts and limitations. PACE 1997; 6(Pt. II): 781–787. 46 Brignole M, Menozzi C. Methods other than tilt testing for diagnosing neurocardiogenic (neurally mediated) syncope. PACE 1997; 6(Pt. II): 795–800. 47 Petersen MEV, Williams TR, Erickson M, et al. Right ventricular pressure, dP/dt and PEI, during tilt induced vasovagal syncope. PACE 1997; 6(Pt. II): 806–809. 48 Brignole M, Menozzi C, Corbucci G, et al. Detecting incipient vasovagal syncope: Intraventricular acceleration. PACE 1997; 6(Pt. II): 801–805. 49 Grubb BP, Wolfe DA, Samoil D, et al. Adaptive rate pacing controlled by right ventricular pre-ejection interval for severe refractory orthostatic hypotension. PACE 1993; 16: 801–805. 50 Slotwiner DJ, Stein KM, Lippman N, et al. Response to β-blocker therapy of neurocardiogenic syncope: Interaction between age and parasympathetic tone. PACE 1997; 6(Pt. II): 810–814. 51 Benditt DG, Yi Z, Hansen R, et al. Seemingly inappropriate QT interval changes during head-up tilt testing: A marker of imminent neurally mediated syncope. PACE 1993; 6(Pt. II): 861. 52 Kapoor W, Keirpf M, Maher Y, et al. Syncope of unknown origin: The need for a more cost-effective approach to its evaluation. JAMA 1982; 247: 2687–2691. 53 Calkins H, Byrne M, El-Atassi R, et al. The Economic Burden of unrecognized vasodepressor syncope. Am J Med 1993; 95: 473–479. 54 Sutton R, Petersen M. The economics of treating vasovagal syncope. PACE 1997; 6(Pt. II): 849–850. 55 Dey AB, Bexton RS, Tyman MM, et al. Impact of a dedicated "syncope and falls" clinic on pacing practice in the northeast of England. PACE 1997; 6(Pt. II): 815–817. 56 Dey AB, Stout NR, Kenny RA. Cardiovascular syncope is the most common cause of drop attacks in the elderly. PACE 1997; 6(Pt. II): 818–819. 57 Richardson DA, Bexton R, Shaw FE, et al. Prevalence of cardioinhibitory carotid sinus hypersensitivity in patients 50 years or over presenting to the accident and emergency department with "unexplained" or "recurrent" falls. PACE 1997; 6(Pt. II): 820–823. 58 Fitzpatrick AP, Ahmed R, Williams S, et al: A randomized trial of medical therapy in malignant vasovagal syndrome or neurally mediated bradycardia/hypotension syndrome. Eur JCPE 1991; 1: 991–202. 59 Brignole M, Menozzi C, Gianfranchi L, et al. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992; 70: 339–342. 60 Morillo CA, Leitch JU, Yee R, et al. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993; 22: 1843–1848. 61 Moya A, Permanyer-Miralda G, Sagrista-Sauleda J, et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: Results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 1995; 25: 65–69. 62 Sheldon R, Rose S, Flanagan P, et al. Risk factors for syncope recurrence after a positive tilt table test in patients with syncope. Circulation 1996; 93: 973–981. 63 Benditt DG, Remole S, Asso A, et al. Cardiac pacing for carotid sinus syndrome and vasovagal syncope. In SS Barold, J Mugica (eds.): New Perspectives in Cardiac Pacing, 3. Mount Kisco , NY , Futura Publishing Co., 1993, pp. 15–28. 64 Brignole M, Menozzi C, Lolli G, et al. Long term outcome paced and nonpaced patients with severe carotid sinus syndrome. Am J Cardiol 1992; 69: 1039–1043. 65 Benditt DG, Peterson M, Lurie K, et al. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Int Med 1995; 122: 204–209. 66 Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, et al. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994; 71: 274–281. 67 Benditt DG, Sutton R, Gammage M, et al., and the International Rate Drop Investigators Group. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. PACE 1997; 6(Pt. II): 832–839. 68 Gammage MD. Tilt testing: A useful screen for rate-drop response. PACE 1997; 6(Pt. II): 829–831. 69 Gammage MD. Rate-drop response programming. PACE 1997; 6(Pt. II): 841–843. 70 Sheldon RS, Gent M, Roberts RS, et al. North American vasovagal pacemaker study: Study design and organization. PACE 1997; 6(Pt. II): 844–848. Citing Literature Volume20, Issue3March 1997Pages 851-860 ReferencesRelatedInformation